These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38012410)

  • 1. Severe dengue progression beyond enhancement.
    Odio CD; Aogo RA; Lowman KE; Katzelnick LC
    Nat Immunol; 2023 Dec; 24(12):1967-1969. PubMed ID: 38012410
    [No Abstract]   [Full Text] [Related]  

  • 2. Advancing dengue vaccine development.
    Feinberg MB; Ahmed R
    Science; 2017 Nov; 358(6365):865-866. PubMed ID: 29146795
    [No Abstract]   [Full Text] [Related]  

  • 3. Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients.
    Chaichana P; Okabayashi T; Puiprom O; Sasayama M; Sasaki T; Yamashita A; Ramasoota P; Kurosu T; Ikuta K
    PLoS One; 2014; 9(3):e92173. PubMed ID: 24642752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement.
    Fink AL; Williams KL; Harris E; Alvine TD; Henderson T; Schiltz J; Nilles ML; Bradley DS
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005721. PubMed ID: 28686617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice.
    Ramasamy V; Arora U; Shukla R; Poddar A; Shanmugam RK; White LJ; Mattocks MM; Raut R; Perween A; Tyagi P; de Silva AM; Bhaumik SK; Kaja MK; Villinger F; Ahmed R; Johnston RE; Swaminathan S; Khanna N
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006191. PubMed ID: 29309412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substitution of the precursor peptide prevents anti-prM antibody-mediated antibody-dependent enhancement of dengue virus infection.
    Wang Y; Si LL; Guo XL; Cui GH; Fang DY; Zhou JM; Yan HJ; Jiang LF
    Virus Res; 2017 Feb; 229():57-64. PubMed ID: 27939945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of antibody concentration as the main parameter in a dengue virus antibody-dependent enhancement assay using FcγR-expressing BHK cells.
    Moi ML; Takasaki T; Saijo M; Kurane I
    Arch Virol; 2014 Jan; 159(1):103-16. PubMed ID: 23900750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model.
    Libraty DH; Acosta LP; Tallo V; Segubre-Mercado E; Bautista A; Potts JA; Jarman RG; Yoon IK; Gibbons RV; Brion JD; Capeding RZ
    PLoS Med; 2009 Oct; 6(10):e1000171. PubMed ID: 19859541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease.
    Zellweger RM; Prestwood TR; Shresta S
    Cell Host Microbe; 2010 Feb; 7(2):128-39. PubMed ID: 20153282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dengue hemorrhagic fever in infants: report of two cases].
    Mourão MP; Lacerda MV; Bastos Md Mde S; Albuquerque BC; Alecrim WD
    Rev Soc Bras Med Trop; 2004; 37(2):175-6. PubMed ID: 15094905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1β Secretion: A Primary Human Monocyte Model.
    Callaway JB; Smith SA; Widman DG; McKinnon KP; Scholle F; Sempowski GD; Dittmer DP; Crowe JE; de Silva AM; Ting JP
    PLoS One; 2015; 10(8):e0136708. PubMed ID: 26301593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent enhancement in dengue virus infections.
    Burke DS; Kliks S
    J Infect Dis; 2006 Feb; 193(4):601-3; author reply 603-4. PubMed ID: 16425141
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody fucosylation predicts disease severity in secondary dengue infection.
    Bournazos S; Vo HTM; Duong V; Auerswald H; Ly S; Sakuntabhai A; Dussart P; Cantaert T; Ravetch JV
    Science; 2021 Jun; 372(6546):1102-1105. PubMed ID: 34083490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection.
    Ramadhany R; Hirai I; Sasaki T; Ono K; Ramasoota P; Ikuta K; Kurosu T
    Antiviral Res; 2015 Dec; 124():61-8. PubMed ID: 26522769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Simulations Reveal the Role of Antibody Fine Specificity and Viral Maturation State on Antibody-Dependent Enhancement of Infection in Dengue Virus.
    Ripoll DR; Wallqvist A; Chaudhury S
    Front Cell Infect Microbiol; 2019; 9():200. PubMed ID: 31275864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue virus infection-enhancing and neutralizing antibody balance in children of the Philippines and Indonesia.
    Yamanaka A; Tabuchi Y; Mulyatno KC; Susilowati H; Hendrianto E; Soegijanto S; Konishi E
    Microbes Infect; 2012 Nov; 14(13):1152-9. PubMed ID: 22841680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus.
    Renner M; Flanagan A; Dejnirattisai W; Puttikhunt C; Kasinrerk W; Supasa P; Wongwiwat W; Chawansuntati K; Duangchinda T; Cowper A; Midgley CM; Malasit P; Huiskonen JT; Mongkolsapaya J; Screaton GR; Grimes JM
    Nat Immunol; 2018 Nov; 19(11):1248-1256. PubMed ID: 30323338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to dengue fever--the good, the bad, and the ugly?
    Schmidt AC
    N Engl J Med; 2010 Jul; 363(5):484-7. PubMed ID: 20818870
    [No Abstract]   [Full Text] [Related]  

  • 19. Structural perspectives of antibody-dependent enhancement of infection of dengue virus.
    Morrone SR; Lok SM
    Curr Opin Virol; 2019 Jun; 36():1-8. PubMed ID: 30844538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue Antibody and Zika: Friend or Foe?
    Durbin AP
    Trends Immunol; 2016 Oct; 37(10):635-636. PubMed ID: 27599407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.